MORGANTOWN, W.V., April 8, 2014 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. (OTCBB:PRGB) (“Protea”), announced today that Greg Kilby, Ph.D. has joined the Company as its Chief Bioanalytics Officer (CBO) and Director of Biomolecular Information Services. Prior to joining Protea Dr. Kilby held the position of Director, North America Life Sciences Mass Spectrometry Application and Demonstration Laboratories for Thermo Fisher Scientific (NYSE:TMO) and previously held positions at Agilent Technologies, Inc. and Pfizer, Inc.
Help employers find you! Check out all the jobs and post your resume.
